array(12) { ["code"]=> string(5) "en_gb" ["id"]=> string(2) "64" ["native_name"]=> string(6) "Global" ["major"]=> string(1) "0" ["active"]=> string(1) "1" ["default_locale"]=> string(5) "en_GB" ["encode_url"]=> string(1) "0" ["tag"]=> string(5) "en-gb" ["translated_name"]=> string(6) "Global" ["url"]=> string(25) "https://www.prosigna.com/" ["country_flag_url"]=> string(90) "https://www.prosigna.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/en_gb.png" ["language_code"]=> string(5) "en_gb" } native: Global
translated: Global
IN the US
OUTSIDE the US
×
CONTACT US
You are now entering a page intended for healthcare professionals only, if you are a patient or a member of the public, we will address you to a dedicated webpage.
I am a healthcare professional
I am a patient
Global
English
US
(
English
)
France
(
Français
)
Germany
(
Deutsch
)
Italian
(
Italiano
)
Español
(
Spanish
)
Why Prosigna
Resources
Patients
Contact Us
CE-IVD
marked
&
recommended in guidelines
THE TEST to answer more than one question
The breast cancer risk of recurrence test that confidently guides treatment decisions.
Why Prosigna
Resources